(Reuters) - Corgenix Medical Corp said on Thursday the U.S. Food and Drug Administration approved its Ebola test for emergency use. The company's so-called ReEBOV Antigen Rapid Test involves putting a drop of blood on a small paper strip and waiting for 15-25 minutes for a reaction. The test is able to correctly identify about 92 percent of Ebola-infected patients and 85 percent of those not infected with the virus, the World Health Organization said earlier this month. (Reporting by Natalie Grover in Bengaluru; Editing by Maju Samuel) via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment